Nov 30 (Reuters) – Elon Musk said on Wednesday he expects a wireless brain chip developed by his company Neuralink to begin human clinical trials in six months, after the company missed earlier timelines set by him. The company is developing brain chip interfaces that it says could enable disabled patients to move and communicate … Read more
Cyber Monday spending to hit $11.6 bln – report Crypto shares fall on BlockFi bankruptcy filing Biogen down after death in Alzheimer drug trial Indexes end: S&P 500 -1.54%, Nasdaq -1.58%, Dow -1.45% Nov 28 (Reuters) – US stocks ended sharply lower on Monday after protests in major Chinese cities against strict COVID-19 policies sparked … Read more
Must prepare for scenario where ties with China sour Comments come day after Scholz trip to Beijing Tells German CEOs to diversify away from China BERLIN, Nov 5 (Reuters) – German Chancellor Olaf Scholz, who was heavily criticized for a trip to Beijing this week, said on Saturday his and Chinese President Xi Jinping’s joint … Read more
CHICAGO, July 29 (Reuters) – People at high risk of severe disease who have yet to get a second COVID-19 booster should not wait for next-generation, Omicron-targeted vaccines expected in the fall, five vaccine experts told Reuters. In many countries, including the United States, the BA.5 Omicron subvariant of the virus is surging, but current … Read more
A medical worker administers a dose of the “Cominarty” Pfizer-BioNTech coronavirus disease (COVID-19) vaccine to a patient at a vaccination center in Ancenis-Saint-Gereon, France, November 17, 2021. REUTERS/Stephane Mahe/File Photo /File Photo Register now for FREE unlimited access to Reuters.com Register July 28 (Reuters) – The following is a summary of some recent studies on … Read more